Skip to main content

Table 2 Angiographic and procedural characteristics

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Characteristics

DM

P

No-DM

P

G2‑DES

N = 1862

BP‑DES

N = 421

G2‑DES

N = 4232

BP‑DES

N = 1151

Lesions involving LM

46 (2.5)

9 (2.1)

0.688

81 (1.9)

15 (1.3)

0.165

Lesions involving LAD

1703 (91.5)

377 (89.5)

0.213

3929 (92.8)

1050 (91.2)

0.065

Lesions involving LCX

308 (16.5)

56 (13.3)

0.101

565 (13.4)

163 (14.2)

0.476

Lesions involving RCA

373 (20.0)

94 (22.3)

0.292

713 (16.8)

183 (15.9)

0.444

Number of lesions treated

1.4 ± 0.6

1.4 ± 0.6

0.664

1.3 ± 0.59

1.34 ± 0.60

0.013

Number of stents

1.8 ± 1.0

1.7 ± 0.9

0.177

1.75 ± 0.89

1.67 ± 0.88

0.391

Number of target vessel

 Single vessel

386 (20.7)

70 (16.6)

0.057

1320 (31.2)

340 (29.5)

0.282

 Double vessel

576 (30.9)

143 (34.0)

0.578

1316 (31.1)

379 (32.9)

0.236

 Triple vessel

779 (41.8)

185 (43.9)

0.429

1349 (31.9)

378 (32.8)

0.534

SYNTEX score

11.7 ± 8.0

11.9 ± 8.2

0.684

10.9 ± 7.7

11.0 ± 7.8

0.329

Normal origin of coronary artery

1774 (95.3)

403 (95.7)

0.692

4051 (95.7)

1102 (95.7)

0.977

Right distribution of coronary artery

1633 (87.7)

382 (90.7)

0.081

3747 (88.5)

1019 (88.5)

0.994

Transradial approach

1664 (89.4)

375 (89.1)

0.861

3813 (90.1)

1011 (87.8)

0.026

Pulling out sheath directly

1408 (75.6)

328 (77.9)

0.320

3277 (77.4)

904 (78.5)

0.424

IVUS application

97 (5.2)

16 (3.8)

0.229

218 (5.2)

58 (5.0)

0.878

IABP application

25 (1.3)

5 (1.2)

0.801

40 (0.9)

12 (1.0)

0.765

TIMI flow before PCI

 0

321 (17.2)

71 (16.9)

0.995

678 (16.0)

235 (20.4)

< 0.001

 1

61 (3.3)

20 (4.8)

0.626

123 (2.9)

35 (3.0)

0.811

 2

221 (11.9)

36 (8.6)

0.290

483 (11.4)

125 (10.9)

0.599

 3

1259 (67.6)

294 (69.8)

0.247

2948 (69.7)

756 (65.7)

0.010

TIMI flow after PCI

 0

21 (1.1)

6 (1.4)

0.593

41 (1.0)

12 (1.0)

0.822

 1

3 (0.2)

0 (0)

> 0.999

9 (0.2)

3 (0.3)

0.728

 2

10 (0.5)

4 (1.0)

0.226

30 (0.7)

11 (1.0)

0.393

 3

1828 (98.2)

411 (97.6)

0.754

4152 (98.1)

1125 (97.7)

0.425

B2 or C lesions

1430 (76.8)

330 (78.4)

0.484

3101 (73.3)

885 (76.9)

0.013

severe calcification

72 (3.9)

13 (3.1)

0.446

115 (2.7)

29 (2.5)

0.712

CTO lesions

143 (7.7)

30 (7.1)

0.698

267 (6.3)

107 (9.3)

< 0.001

Ostial lesions

316 (17.0)

66 (15.7)

0.521

697 (16.5)

178 (15.5)

0.413

Bifurcation lesions

346 (18.6)

77 (18.3)

0.889

825 (19.5)

239 (20.8)

0.337

Thrombosis

67 (3.6)

15 (3.6)

0.972

173 (4.1)

50 (4.3)

0.699

  1. DM diabetes mellitus, BP-DES biodegradable polymer drug-eluting stents, G2-DES second generation drug-eluting stents, LM left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, SYNTEX synergy between percutaneous coronary interventions with TAXUS and cardiac surgery, IVUS intravascular ultrasound, IABP intra-aortic balloon pump, TIMI thrombolysis in myocardial infarction, PCI percutaneous coronary intervention, CTO chronic total occlusion